Pathogenetic aspects of the obese-hyperglycemic syndrome in mice (genotypeobob): II. Extrapancreatic factors
Tóm tắt
The cause of the pronounced insulin resistance of the hereditary obese-hyperglycemic syndrome in mice (obob) is so far unknown. To evaluate whether growth hormone (GH) is of pathogenetic significance in this context thein vivo incorporation of sulfate into costal cartilage was measured in obese-hyperglycemic mice and their lean littermates at various ages. It was found that a) GH administration raised the sulfation activity of the costal cartilage in both types of mice; b) the hormone further increased the insulin resistance of the obesehyperglycemic animals; c) the sulfate incorporation of the obese mice was considerably elevated after 1 month of age and remained high until the age of about 10 months. In 17 months old animals it had returned to a level similar to that of the lean littermates. In addition, the epiphyseal width of the tibia was increased in the obese mice. Since it was not clear whether the increased rate of sulfate in corporation was due to an elevated endogenous GH activity and/or the high serum insulin levels prevailing in the obese mice at this period of life a study of the pituitary morphology was carried out. The lack of obvious structural or quantitative differences between the pituitary alpha cells of the lean and obese mice did not exclude the possibility that the elevated sulfation activity was caused by the high serum insulin levels rather than an increased circulating GH activity. — Glucokinase activity, characterized by a highK
m value, was found in the livers of both lean and obese mice. A significant elevation of this enzyme activity, but not of the hexokinase activity, in the obese mice strongly suggests that the insulin resistance does not extend to the liver cells in the obese-hyperglycemic syndrome.
Tài liệu tham khảo
Ailabouni, H., Dikstein, S., Zor, U., Sulman, F.G.: Specificity of the “tibia test” in intact immature female rats. J. Endocr.35, 393–399 (1966).
Barnes, B.G-.: Electron microscope studies on the secretory cytology of the mouse anterior pituitary. Endocrinology71, 618–628 (1962).
Batt, R., Mialhe, R.: Insulin resistance of the inherently obese mouse-obob. Nature212, 289–290 (1966).
Chalkley, H.W.: Method for the quantitative morphologic analyses of tissues. J. nat. Cancer Inst.4, 47–53 (1943).
Evans, H.M., Simpson, M.E., Marx, W., Kirbrick, E.: Bioassay of the pituitary growth hormone. Width of the proximal epiphyseal cartilage of the tibia in hypophysectomized rats. Endocrinology32, 13–16 (1943).
Hales, C.N., Randle, P.J.: Immunoassay of insulin with antibody precipitate. Biochem. J.88, 137–146 (1963).
Herbai, G.: Acta physiol. scand., in press.
- Westman, S., Hellerström, C.: The growth hormone dependent incorporation of sulfate into the costal cartilage of obese-hyperglycemic mice of different ages. Acta endocr. In press.
Hjelm, M., deVerdier, C.-H.: A methodological study of the enzymatic determination of glucose in blood. Scand. J. clin. Lab. Invest.15, 415–428 (1963).
Lauris, V., Cahill, G.F., Jr.: Hepatic glucose phosphotransferase. Diabetes15, 475–479 (1966).
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R. J.: Protein measurement with the folin phenol reagent. J. biol. Chem.193, 265–275, (1951).
Martin, J.M., Akerblom, H.K., Garay, G.: Insulin secretion in rats with elevated levels of circulating growth hormone due to MtT-W15 tumor. Diabetes17, 661–667 (1968).
Maxwell, T., Jr.: A controllable differential stain for the hypophysis by adaptation of the Mallory triple stain. Stain Technol.13, 93–96 (1938).
Mayer, J., Russel, R.E., Bates, M.W., Dickie, M.M.: Metabolic, nutritional and endocrine studies of the hereditary obesity-diabetes syndrome of mice and mechanism of its development. Metabolism2, 9–21 (1953).
Moewis, G.: Personal communication.
Reynolds, E.S.: The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. cell. Biol.17, 208–212 (1963).
Salas, M., Vinuela, E., Sols, A.: Insulin-dependent synthesis of liver glucokinase in the rat. J. biol. Chem.238, 3535–3538 (1963).
Salmon, W.D., Jr., DuVall, M.R., Thompson, E.Y.: Stimulation by insulin in vitro of incorporation of (35S) sulfate and (14C) leucine into protein-polysaccharide complexes, (3H) uridine into RNA, and (3H) thymidine into DNA of costal cartilage from hypophysectomized rats. Endocrinology82, 493–499 1968.
Seidman, I., Horland, A.A., Teebor, G.W.: Hepatic glycolytic and gluconeogenic enzymes of the obesehyperglycemic mouse. Biochim. biophys. Acta146, 600–603 (1967).
Shull, K., Mayer, J.: Analysis of the blood sugar response of obese-hyperglycemic mice and normal mice to hormones: growth hormone, cortisone and corticotropin. Endocrinology58, 1–7 (1956).
Stauffacher, W., Lambert, A.E., Vecchio, D., Renold, A.E.: Measurements of insulin activities in pancreas and serum of mice with spontaneous (“Obese” and “New Zealand Obese”) and induced (goldthioglucose) obesity and hyperglycemia, with considerations on the pathogenesis of the spontaneous syndrome. Diabetologia3, 230–237 (1967).
Watson, M.L.: Staining of tissue sections for electron microscopy with heavy metals. J. biophys. biochem. Cytol.4, 474–478 (1958).
Westman, S.: Development of the obese-hyperglycemic syndrome in mice. Diabetologia4, 141–149 (1968).